David S. McCullough
Amministratore Delegato presso Enterin, Inc.
Provenienza dei contatti di primo grado di David S. McCullough
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
30
| Public Company | Pharmaceuticals: Major | 30 |
| Public Company | Biotechnology | 26 | |
Enterin, Inc.
 Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA.
11
| Holding Company | Biotechnology | 11 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a David S. McCullough tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Private Equity Investor Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Founder | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Private Equity Investor Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chairman President | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| BAYER AG | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Sales & Marketing | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
E. Merck KG
 E. Merck KG Pharmaceuticals: MajorHealth Technology E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Chairman Director/Board Member | |
EMD Pharmaceuticals, Inc.
 EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal General Counsel Human Resources Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Chief Executive Officer Director of Finance/CFO Comptroller/Controller/Auditor Director/Board Member | |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Pharmaceuticals: Major | Chief Executive Officer Sales & Marketing Corporate Officer/Principal | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
Hatteras Venture Partners
 Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | Investment Managers | Consultant / Advisor Private Equity Investor Consultant / Advisor | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree Undergraduate Degree | |
| EON SE | Electric Utilities | Director/Board Member Chairman | |
| Vanderbilt University | College/University | Director/Board Member Doctorate Degree | |
| KINIKSA PHARMACEUTICALS, LTD. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| MORPHOSYS AG | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Undergraduate Degree Doctorate Degree | |
| ARMO BIOSCIENCES INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| The University of North Carolina at Chapel Hill | College/University | Masters Business Admin Undergraduate Degree | |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree | |
Star Therapeutics, Inc.
 Star Therapeutics, Inc. BiotechnologyHealth Technology Star Therapeutics, Inc. is an American company that aims to develop life-changing therapies for rare diseases. The company's mission is to help millions of patients in urgent need. The company was founded by Adam Rosenthal, who has been the CEO since incorporation. | Biotechnology | Director/Board Member Director/Board Member | |
Electra Therapeutics, Inc.
 Electra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Electra Therapeutics, Inc. is a clinical stage biotechnology company that develops therapies for the treatment of immunological diseases and cancer. The company is based in San Francisco, CA. The company's lead product candidate, ela026, is a monoclonal antibody that targets sirp on the cell surface of and t cells, and precisely depletes pathological immune cells. Electra currently has one program in clinical development and additional preclinical programs. The company was founded by Adam Rosenthal, who has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Procom RX | Chairman Chief Executive Officer | ||
Project HOPE-The-People-To-People HealthFoundation, Inc.
 Project HOPE-The-People-To-People HealthFoundation, Inc. Medical/Nursing ServicesHealth Services Project HOPE-The-People-To-People HealthFoundation, Inc. provides solutions to health problems. The firm trains health professionals and build medical facilities in areas devastated by conflict, natural disasters, and poverty. It addresses infectious diseases, health professional education, women's and children's health, humanitarian assistance, and the need for health systems and facilities. The company was founded by William B. Walsh in 1958 and is headquartered in Millwood, VA. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
NC Life Sciences Organization
 NC Life Sciences Organization Miscellaneous Commercial ServicesCommercial Services North Carolina Biosciences Organization is non-profit organization, which focuses on legislative monitoring and lobbying activities at the state and federal level. The company was founded in 1994 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| North Carolina State University | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of North Carolina at Charlotte | College/University | Graduate Degree Masters Business Admin | |
EnteroBiotix Ltd.
 EnteroBiotix Ltd. Medical SpecialtiesHealth Technology EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom. | Medical Specialties | Chairman | |
Horizon Therapeutics Switzerland GmbH
 Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | Pharmaceuticals: Major | Founder | |
UCB Pharma GmbH
 UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Merck Serono GmbH
 Merck Serono GmbH Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck Serono GmbH is a German pharmaceutical company that manufactures and distributes pharmaceutical products. The company is based in Darmstadt, Germany. The CEOs of the company are Matthias Pfannkuche, Angelika Heinl, Sören Hermansson. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Johann Wolfgang Goethe-Universität Frankfurt am Main | College/University | Undergraduate Degree | |
| BIOXXMED AG | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 32 |
| Germania | 12 |
| Svizzera | 5 |
| Regno Unito | 4 |
Settori
| Health Technology | 32 |
| Consumer Services | 10 |
| Commercial Services | 4 |
| Finance | 3 |
| Utilities | 2 |
Posizioni
| Director/Board Member | 332 |
| Corporate Officer/Principal | 185 |
| Independent Dir/Board Member | 84 |
| Chairman | 77 |
| Chief Executive Officer | 54 |
Contatti più connessi
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Kenneth Lee | 40 |
| Beth Seidenberg | 39 |
| Charlie Sanders | 38 |
| Karl-Ludwig Kley | 32 |
| Elmar Schnee | 31 |
| George Abercrombie | 26 |
| David Smoller | 21 |
| Nancy Hutson | 19 |
| Randolph Steer | 19 |
| Mark Finn | 16 |
| Bernhard R. M. Ehmer | 16 |
| Theo Siegert | 16 |
| Rolf Krebs | 15 |
| Irwin Scher | 14 |
- Borsa valori
- Insiders
- David S. McCullough
- Connessioni Società
